+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genetic Testing. Global Market Forecasts for Applications and Technologies. Updated for COVID-19 Pandemic impact With Executive and Consultant Guides

  • ID: 5459736
  • Report
  • May 2022
  • Region: Global
  • 490 Pages
  • Howe Sound Research
Explosion in Genetic Knowledge Creates New Global Market for Diagnostics. Direct to Consumer Market Shifts

FEATURED COMPANIES

  • 10x Genomics, Inc
  • Biolidics Ltd
  • Excellerate Bioscience
  • Guardant Health
  • MDx Health
  • Personalis
Is genomic cancer testing bouncing back? What has happened to Direct to Consumer testing? Will all newborns receive Whole Genomic Sequencing at birth?

The role of genetics in health and disease is just now being understood. This new knowledge, combined with lower pricing is driving the Genetic Testing industry to record growth. New drugs may only work for people with a certain genetic makeup, and this too is driving the Genetic Testing Industry. The traditional genetic testing market is growing in volume and growing in the breadth of tests creating new life, and new problems for the industry. The report includes detailed breakouts for 14 countries and 5 regions.

Predictive Diagnostics? Pharmacogenomic Testing? Direct to Consumer? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.

This research will make you the expert in your organization. Get the research team working for you by ordering all, or a portion, of this comprehensive report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

The report includes five year market forecasts.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 10x Genomics, Inc
  • Biolidics Ltd
  • Excellerate Bioscience
  • Guardant Health
  • MDx Health
  • Personalis

1 Market Guides
1.1 Genetic Testing - Strategic Situation Analysis & Company Rankings
1.1.1 Selected Genetic Testing Companies Revenue & Growth
1.1.2 Selected Companies Growth Chart
1.2 Guide for Executives, Marketing, Sales and Business Development Staff
1.3 Guide for Management Consultants and Investment Advisors


2 Introduction and Market Definition 
2.1 Genetic Testing Definition in This Report 
2.2 The Genomics Revolution 
2.3 Market Definition
2.3.1 Revenue Market Size
2.3.2 Newborn Screening
2.3.3 Non-Invasive Pregnancy Testing
2.3.4 Predictive
2.3.5 Oncology
2.3.6 Direct to Consumer
2.3.7 Other Application
2.3.8 PCR 
2.3.9 NGS 
2.3.10 Cytogenetic
2.3.11 Other Technology 
2.4 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
2.4.1 Global Healthcare Spending
2.4.2 Spending on Diagnostics
2.4.Important Role of Insurance for Diagnostics
2.5 Chromosomes, Genes and Epigenetics 
2.5.1 Chromosomes
2.5.2 Genes 
2.5.3 Epigenetics


3 Market Overview
3.1 Market Participants Play Different Roles
3.1.1 Supplier/pharmaceutical 
3.1.2 Independent lab specialized/esoteric
3.1.3 Independent lab national/regional 
3.1.4 Independent lab analytical 
3.1.5 Public National/regional lab
3.1.6 Hospital lab
3.1.7 Physician lab
3.1.8 DTC Lab
3.1.9 Independent Genetic Testing Lab
3.1.10 Audit Body 
3.2 Genetic Tests - Types, Examples and Discussion 
3.2.1 Preimplantation Genetic Diagnosis- An Emerging Market
3.2.2 Prenatal Diagnosis - New Technologies Create Opportunity
3.2.3 Newborn Screening
3.2.4 Diagnostic Testing 
3.2.5 Carrier Testing
3.2.6 Predictive and Presymptomatic Testing
3.2.7 Pharmacogenomics 
3.2.8 Forensic Testing
3.2.9 Parental Testing 
3.2.10 Ancestral Testing
3.3 Industry Structure
3.3.1 Hospital’s Testing Share 
3.3.2 Economies of Scale
3.3.3 Hospital vs. Central Lab
3.3.4 Physician Office Lab’s
3.3.5 Physician’s and POCT


4 Market Trends
4.1 Factors Driving Growth 
4.1.1 Genetic Discoveries Creating New Diagnostic Markets
4.1.2 Aging Population a Boon for Diagnostics
4.1.3 Pharmacogenomics Drives Further Growth
4.1.4 Oncology and Liquid Biopsy Enter New Era
4.1.5 Fertility Practice Growth drives market
4.1.6 Direct to Consumer begins to break out 
4.2 Factors Limiting Growth
4.2 Increased Competition Lowers Price
4.2.2 Lower Costs
4.2.3 Testing usage analysis curtailing growth 
4.2.4 Wellness has a downside
4.3 Instrumentation and Automation
4.3 Instruments Key to Market Share
4.3.2 Bioinformatics Plays a Role
4.4 Diagnostic Technology Development
4.4.1 Next Generation Sequencing Fuels a Revolution
4.4.2 Impact of NGS on pricing 
4.4.3 POCT/Self Testing Disruptive Force
4.4.4 Pharmacogenomics Blurs Diagnosis and Treatment
4.4.5 CGES Testing, A Brave New World
4.4.6 Biochips/Giant magneto resistance-based assay


5 Genetic Testing Recent Developments
5.1 Importance of This Section
5.1.2 How to Use This Section 
5.2 Tesis Labs Raises $20M
5.3 Sema4: Sema4 Elements
5.4 Clarified Precision Medicine Acquires Interpares Biomedicine 
5.5 Genetic Technologies to Acquire DTC Genetic Test Provider EasyDNA
5.6 Illumina, Belgium Genetic Centers Partner on WGS-Based Dx 
5.7 NIH, Genomics England Launch Sequencing Studies Using Nanopore Technology
5.8 Progenity Revenues Fall on COVID-19 Effect 
5.9 Natera Launches Tumor Genomic Profiling Assay 
5.10 23andMe To Go Public 
5.11 Guardant Health to Offer Tumor Tissue Sequencing
5.12 Ancestry Quits Health Offering 
5.13 DTC Firm MyDNA Merges With Gene by Gene
5.14 Aetna Coverage for NIPT to Include All Pregnancies
5.15 Agios Pharmaceuticals, PerkinElmer Partner on Hereditary Anemia Genetic Testing
5.16 Tumor, Germline Testing of Cancer Patients Can Give Discordant Results
5.17 Invitae Completes Acquisition of ArcherDx
5.18 Prenetics Receives $15M Investment
5.19 Sanford Health Invests $800K in TruGenomix as Part of PTSD Test Alliance 
5.20 Preconception Carrier Screening Trial Begins in Australia
5.21 Genetic Testing Clinical Use Just Beginning
5.22 Fulgent Genetics Q1 Revenues Jump 44 Percent
5.23 Blueprint Genetics, NICER Consortium Developing Genetic Test for Immunologic, Hematologic Disorders
5.24 Natera Terminates Qiagen Agreement for Developing NGS-Based Genetic Tests
5.25 Invitae Acquires Three Companies: YouScript, Genelex, Diploid
5.26 PerkinElmer SCID Test Chosen for Newborn Screening Evaluation in England
5.27 Germline Cancer Risk Mutations Sometimes Reported in Tumor Testing
5.28 Blueprint Genetics, Archimedlife to Launch Genetic Testing in North America
5.29 Invitae to Offer No-Charge Genetic Testing to Pancreatic Cancer Patients
5.30 Phosphorus Offers DNA Testing to Assess Disease Risk 
5.31 Arivale Shuts Down Personalized Wellness Business
5.32 ArcherDX Acquires Baby Genes
5.33 MDxHealth, LifeLabs Ink Distribution Agreement for Prostate Cancer Assay 
5.34 Thermo Fisher Purchases 9 Percent Stake in Yourgene Health
5.35 Invitae Partners to Expand Free Epilepsy Genetic Testing Program
5.36 Illumina, Chinese Firm Partner on NGS System for Genetic Disease Dx
5.37 NanoString Technologies Prices $103.5M Common Stock Offering
5.38 Canine Consumer Genomics Firm Embark Veterinary Raises $10M
5.39 Yourgene Health to Acquire Elucigene
5.40 Helix, AdventHealth Partner on Genetic Screening Study


6 Profiles of Key Companies
6.1 10x Genomics, Inc
6.2 23andME Inc
6.3 Abbott Diagnostics 
6.4 Adaptive Biotechnologies
6.5 Admera Health, LLC.
6.6 Agena Bioscience, Inc
6.7 Agilent/Dako
6.8 Akonni Biosystems
6.9 Ancestry.com LLC
6.10 Anchor Dx
6.11 Arc Bio
6.12 ARUP Laboratories
6.13 Asuragen
6.14 Baylor Miraca Genetics Laboratories
6.15 Beckman Coulter Diagnostics
6.16 Becton, Dickinson and Company  
6.17 BGI Genomics Co. Ltd
6.18 Bioarray Genetics
6.19 Biocept, Inc. 
6.20 Biodesix Inc. 
6.21 BioFluidica
6.22 BioGenex 
6.23 Biolidics Ltd
6.24 bioMérieux Diagnostics
6.25 Bioneer Corporation
6.26 Bio-Rad Laboratories, Inc.
6.27 Bio-Techne
6.28 C2i Genomics
6.29 Cancer Genetics 
6.30 Caris Molecular Diagnostics
6.31 CellMax Life 
6.32 Centogene
6.33 Cepheid (Danaher)
6.34 Chronix Biomedical 
6.35 Circulogene 
6.36 Clinical Genomics
6.37 Color Genomics
6.38 Complete Genomics, Inc. - A BGI Company
6.39 Cynvenio
6.40 Dante Labs.
6.41 Datar Cancer Genetics Limited 
6.42 Diasorin S.p.A
6.43 Epic Sciences
6.44 Epigenomics AG
6.45 Eurofins Scientific 
6.46 Excellerate Bioscience
6.47 Exosome Diagnostics
6.48 Fabric Genomics 
6.49 Fluidigm Corp
6.50 Foundation Medicine 
6.51 Freenome 
6.52 FUJIFILM Wako Diagnostics 
6.53 Fujirebio
6.54 Fulgent Genetics 
6.55 Gene by Gene, Ltd
6.56 Genedrive
6.57 GeneFirst Ltd
6.58 Genetic Technologies Ltd. 
6.59 Genetron Holdings
6.60 Genomics England 
6.61 Genomics Personalized Health (GPH)
6.62 GenomOncology
6.63 Genzyme Corporation
6.64 Grail, Inc
6.65 Grifols
6.66 Guardant Health 
6.67 Guardiome
6.68 HeiScreen 
6.69 Helix
6.70 Helomics
6.71 Hologic 
6.72 Horizon Discovery
6.73 HTG Molecular Diagnostics
6.74 Human Longevity, Inc
6.75 iCellate 
6.76 Illumina 
6.77 Incell Dx
6.78 Inivata
6.79 Integrated Diagnostics
6.80 Invitae Corporation 
6.81 Invivoscribe
6.82 Karius
6.83 Macrogen
6.84 MDNA Life SCIENCES, Inc
6.85 MDx Health
6.86 Medgenome
6.87 Meridian Bioscience
6.88 Mesa Biotech (Thermo Fisher)
6.89 MIODx
6.90 miR Scientific
6.91 MNG Labs
6.92 Molecular MD
6.93 NantHealth, Inc
6.94 Natera
6.95 Nebula Genomics
6.96 NeoGenomics 
6.97 NGeneBio 
6.98 Novogene Bioinformatics Technology Co., Ltd
6.99 Omega Bioservices 
6.100 OncoDNA
6.101 OpGen 
6.102 ORIG3N, Inc
6.103 Origene Technologies 
6.104 Oxford Nanopore Technologies
6.105 Panagene
6.106 Perkin Elmer
6.107 Personal Genome Diagnostics
6.108 Personalis
6.109 Precipio
6.110 PrecisionMed
6.111 Promega
6.112 Protagen Diagnostics
6.113 Qiagen Gmbh 
6.114 Quantumdx 
6.115 Roche Molecular Diagnostics
6.116 Roswell Biotechnologies 
6.117 Seegene
6.118 Sema4 Holdings
6.119 Sequencing.com 
6.120 Siemens Healthineers
6.121 simfo GmbH 
6.122 Singlera Genomics Inc
6.123 SkylineDx
6.124 Stratos Genomics
6.125 Sure Genomics, Inc
6.126 Sysmex
6.127 Sysmex Inostics 
6.128 Tempus Labs, Inc
6.129 Tesis Labs
6.130 Thermo Fisher Scientific Inc
6.131 Variantyx
6.132 Veritas Genetics
6.133 Volition 


7 Global Market Size
7.1 Global Market by Country 
7.1.1 Table - Global Market by Country  
7.1.2 Chart - Country Market Shares
7.2 Global Market by Application
7.2.1 Table - Global Market by Application
7.2.2 Chart - Application Share by Year
7.2.3 Chart - Application Segment Growth Rates
7.2.4 Chart - Application Segment Share Shifts 
7.2.5 Chart - Application Segment Share Base Year
7.2.6 Chart - Application Segment Share Final Year
7.3 Global Market by Technology
7.3.1 Table - Global Market by Technology
7.3.2 Chart - Technology Share by Year
7.3.3 Chart - Technology Segment Growth Rates
7.3.4 Chart - Technology Segment Share Shifts 
7.3.5 Chart - Technology Segment Share Base Year
7.3.6 Chart - Technology Segment Share Final Year
7.4 Global Market by Product
7.4.1 Table - Global Market by Product 
7.4.2 Chart - Product Share by Year.
7.4.3 Chart - Product Segment Growth Rates
7.4.4 Chart - Product Segment Share Shifts
7.4.5 Chart - Product Segment Share Base Year
7.4.6 Chart - Product Segment Share Final Year
7.5 Global Market by User
7.5.1 Table - Global Market by User
7.5.2 Chart - User Share by Year 
7.5.3 Chart - User Segment Growth Rates 
7.5.4 Chart - User Segment Share Shifts 
7.5.5 Chart - User Segment Share Base Year 
7.5.6 Chart - User Segment Share Final Year 


8 Market Sizes by Application
8.1 Newborn Testing Market 
8.1.1 Table Newborn - by Country
8.1.2 Chart - Newborn Growth
8.2 NIPT Market
8.2.1 Table NIPT - by Country
8.2.2 Chart - NIPT Growth
8.3 Predictive Testing Market
8.3.1 Table Predictive - by Country
8.3.2 Chart - Predictive Growth
8.4 Oncology Testing Market
8.4.1 Table Oncology - by Country
8.4.2 Chart - Oncology Growth
8.5 DTC Testing Market 
8.5.1 Table DTC - by Country
8.5.2 Chart - DTC Growth
8.6 Other Testing Market
8.6.1 Table Other - by Country
8.6.2 Chart - Other Growth 
 
9 Global Genetic Testing Market by Technology
9.1 PCR Testing Market 
9.1.1 Table PCR - by Country
9.1.2 Chart - PCR Growth
9.2 NGS Market 
9.2.1 Table NGS - by Country
9.2.2 Chart - NGS Growth
9.3 Cytogenetic Testing Market
9.3.1 Table Cytogenetic - by Country
9.3.2 Cytogenetic - Predictive Growth
9.4 Other Testing Market
9.4.1 Table Other - by Country
9.4.2 Chart - Other Growth 


10 Global Genetic Testing Market by Product 
10.1 Instruments Market
10.1.1 Table Instruments - by Country
10.1.2 Chart - Instrument Growth 
10.2 Reagents and Kits Market.
10.2.1 Table Reagents and Kits - by Country
10.2.2 Chart - Reagents and Kits Growth 
10.3 Software Market
10.3.1 Table Software - by Country
10.3.2 Software Growth 
10.4 Services Market
10.4.1 Table Services - by Country
10.4.2 Chart - Services Growth 


11 Global Genetic Testing Market by User
11.1 Academic Market
11.1.1 Table Academic - by Country
11.1.2 Chart - Academic Growth 
11.2 Clinical Market 
11.2.1 Table Clinical - by Country 
11.2.2 Chart - Clinical Growth.
11.3 Pharmaceutical Market
11.3.1 Table Pharmaceutical - by Country
11.3.2 Pharmaceutical - Predictive Growth
11.3.3 Industrial and Other Market
11.4.1 Table Industrial and Other - by Country
11.4.2 Chart - Industrial and Other Growth 


12 The Future of Genetic Testing


13 Appendices
13.1 United States Medicare System: 2021 laboratory Fees Schedule
13.2 II Methodology
13.2.1 II.1 Authors
13.2.2 II.2 Sources


Table of Tables 
Table 1 Leading Genomic Companies Revenue Growth (USD $M)
Table 2 Most Common Traditional Genetic Disorders
Table 3 The Base Pairs.
Table 4 Market Players by Type
Table 5 The Different Types of Genetic Tests
Table 6 Five Factors Driving Growth
Table 7 Four Factors Limiting Growth
Table 8 Key Diagnostic Laboratory Technology Trends
Table 9 Next Generation Sequencing Technologies - Speed and Cost 
Table 10 Global Market by Country
Table 11 Global Market by Application
Table 12 Global Market by Technology
Table 13 Global Market by Product
Table 14 Global Market by User
Table 15 Newborn Segment by Country
Table 16 NIPT Segment by Country
Table 17 Predictive Segment by Country 
Table 18 Oncology Segment by Country 
Table 19 DTC Segment by Country
Table 20 Other Segments by Country
Table 21 PCR Segment by Country
Table 22 NGS Segment by Country
Table 23 Cytogenetic Segment by Country
Table 24 Other Segments by Country
Table 25 Instruments Segment by Country
Table 26 Reagents and Kits Segment by Country
Table 27 Software Segment by Country
Table 28 Services Segment by Country
Table 29 Academic Segment by Country
Table 30 Clinical Segment by Country 
Table 31 Pharmaceutical Segment by Country
Table 32 Industrial and Other Segment by Country
Table 33 2021 CLINICAL LAB FEE SCHEDULE


Table of Figures 
Figure 1 The Lab Test Pie
Figure 2 DNA Strands and Chromosomes
Figure 3 Karyogram of Human Chromosomes
Figure 4 Size of Various Genomes
Figure 5 Percentage of World Population Over 
Figure 6 Country Market Shares 
Figure 7 Application Share by Year
Figure 8 Application Segment Growth Rates
Figure 9 Segment Share Shifts
Figure 10 Application Segment Share Base Year
Figure 11 Application Segment Share Final Year
Figure 12 Technology Share by Year 
Figure 13 Technology Segment Growth Rates 
Figure 14 Technology Segment Share Shifts
Figure 15 Technology Segment Share Base Year
Figure 16 Technology Segment Share Final Year
Figure 17 Product Share by Year
Figure 18 Product Segment Growth Rates
Figure 19 Product Segment Share Shifts.
Figure 20 Product Segment Share Base Year
Figure 21 Product Segment Share Final Year
Figure 22 User Share by Year 
Figure 23 User Segment Growth Rates
Figure 24 User Segment Share Shifts 
Figure 25 User Segment Share Base Year
Figure 26 User Segment Share Final Year 
Figure 27 Newborn vs. Total Market Growth
Figure 28 NIPT vs. Total Market Growth 
Figure 29 Predictive vs. Total Market Growth
Figure 30 Oncology vs. Total Market Growth
Figure 31 DTC vs. Total Market Growth 
Figure 32 Other vs. Total Market Growth
Figure 33 PCR vs. Total Market Growth 
Figure 34 NGS vs. Total Market Growth 
Figure 35 Cytogenetic vs. Total Market Growth
Figure 36 Other vs. Total Market Growth
Figure 37 Instrument vs. Total Market Growth
Figure 38 Reagents and Kits vs. Total Market Growth
Figure 39 Software vs. Total Market Growth 
Figure 40 Services vs. Total Market Growth
Figure 41 Academic vs. Total Market Growth
Figure 42 Clinical vs. Total Market Growth
Figure 43 Pharmaceutical vs. Total Market Growth 
Figure 44 Industrial and Other vs. Total Market Growth

Note: Product cover images may vary from those shown

Loading
LOADING...

  • 10x Genomics, Inc
  • 23andME Inc
  • Abbott Diagnostics 
  • Adaptive Biotechnologies
  • Admera Health, LLC..
  • Agena Bioscience, Inc
  • Agilent/Dako
  • Akonni Biosystems
  • Ancestry.com LLC
  • Anchor Dx
  • Arc Bio
  • ARUP Laboratories
  • Asuragen
  • Baylor Miraca Genetics Laboratories
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company  
  • BGI Genomics Co. Ltd
  • Bioarray Genetics
  • Biocept, Inc. 
  • Biodesix Inc. 
  • BioFluidica
  • BioGenex 
  • Biolidics Ltd
  • bioMérieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne
  • C2i Genomics
  • Cancer Genetics 
  • Caris Molecular Diagnostics
  • CellMax Life 
  • Centogene
  • Cepheid (Danaher)
  • Chronix Biomedical 
  • Circulogene 
  • Clinical Genomics
  • Color Genomics
  • Complete Genomics, Inc. - A BGI Company
  • Cynvenio
  • Dante Labs.
  • Datar Cancer Genetics Limited 
  • Diasorin S.p.A
  • Epic Sciences
  • Epigenomics AG
  • Eurofins Scientific 
  • Excellerate Bioscience
  • Exosome Diagnostics
  • Fabric Genomics 
  • Fluidigm Corp
  • Foundation Medicine 
  • Freenome 
  • FUJIFILM Wako Diagnostics 
  • Fujirebio
  • Fulgent Genetics 
  • Gene by Gene, Ltd
  • Genedrive
  • GeneFirst Ltd
  • Genetic Technologies Ltd. 
  • Genetron Holdings
  • Genomics England 
  • Genomics Personalized Health (GPH)
  • GenomOncology
  • Genzyme Corporation
  • Grail, Inc
  • Grifols
  • Guardant Health 
  • Guardiome
  • HeiScreen 
  • Helix
  • Helomics
  • Hologic 
  • Horizon Discovery
  • HTG Molecular Diagnostics
  • Human Longevity, Inc
  • iCellate 
  • Illumina 
  • Incell Dx
  • Inivata
  • Integrated Diagnostics
  • Invitae Corporation 
  • Invivoscribe
  • Karius
  • Macrogen
  • MDNA Life SCIENCES, Inc
  • MDx Health
  • Medgenome
  • Meridian Bioscience
  • Mesa Biotech (Thermo Fisher)
  • MIODx
  • miR Scientific
  • MNG Labs
  • Molecular MD
  • NantHealth, Inc
  • Natera
  • Nebula Genomics
  • NeoGenomics 
  • NGeneBio 
  • Novogene Bioinformatics Technology Co., Ltd
  • Omega Bioservices 
  • OncoDNA
  • OpGen 
  • ORIG3N, Inc
  • Origene Technologies 
  • Oxford Nanopore Technologies
  • Panagene
  • Perkin Elmer
  • Personal Genome Diagnostics
  • Personalis
  • Precipio
  • PrecisionMed
  • Promega
  • Protagen Diagnostics
  • Qiagen Gmbh 
  • Quantumdx 
  • Roche Molecular Diagnostics
  • Roswell Biotechnologies 
  • Seegene
  • Sema4 Holdings
  • Sequencing.com 
  • Siemens Healthineers
  • simfo GmbH 
  • Singlera Genomics Inc
  • SkylineDx
  • Stratos Genomics
  • Sure Genomics, Inc
  • Sysmex
  • Sysmex Inostics 
  • Tempus Labs, Inc
  • Tesis Labs
  • Thermo Fisher Scientific Inc
  • Variantyx
  • Veritas Genetics
  • Volition 
Note: Product cover images may vary from those shown

Loading
LOADING...